Cardurion logo - click to return to the homepage

Cardurion Pharmaceuticals Further Bolsters Leadership Team with Appointment of Stephen Migausky as General Counsel

Experienced Life Sciences Executive Brings 15 Years of Legal, Corporate Strategy, and Business Development Experience BURLINGTON, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion” or “the Company”), a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today announced the appointment of Stephen Migausky as Senior Vice President […]

This site uses cookies and third-party scripts to provide certain services. View Privacy Policy

Skip to content